Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Cartesian Inc (NASDAQ:CRTN) shares tumbled 26.1 percent to $0.820. Cartesian reported Q4 adjusted loss of $0.03 per share on revenue of $16.9 million.
- Lululemon Athletica inc. (NASDAQ:LULU) shares dipped 22.1 percent to $51.66 after the company reported downbeat earnings for its fourth quarter and issued a weak forecast for the current quarter. Susquehanna downgraded Lululemon from Positive to Neutral, while Citigroup downgraded the stock from Buy to Neutral.
- Exfo Inc (NASDAQ:EXFO) shares slipped 13.9 percent to $5.12 after the company posted weak quarterly earnings. The company also reported that Philippe Morin will succeed Germain Lamonde as new CEO.
- Gevo, Inc. (NASDAQ:GEVO) shares fell 13.7 percent to $1.01 after the company posted a wider-than-expected quarterly loss.
- Science Applications International Corp (NYSE:SAIC) declined 12.5 percent to $75.48 after the company posted downbeat quarterly earnings.
- Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares dropped 11.8 percent to $12.60. Before the open, the company said its SWOG collaborative group clinical study is temporarily closed to enrollment. Halozyme is working with SWOG to interpret the results from the initial data set.
- Cenovus Energy Inc (USA) (NYSE:CVE) shares declined 11.2 percent to $11.62 following announcement of acquisition of Conocophillips 50 percent interest in FCCL Partnership for $17.7B. Cenovus also reported a $3 billion bought-deal offering of 187.5 million common shares at $16 per share.
- Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) tumbled 11 percent to $2.98 after the company reported Q4 results.
- Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) shares declined 10.8 percent to $8.02 even though the company reported positive, top-line data from an ongoing clinical trial. Corbus has been exploring its Anabasum (Resunab) therapy in a Phase 2 study for the treatment of cystic fibrosis.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares dropped 10.6 percent to $4.98 after surging 34.54 percent on Wednesday. Tonix Pharma reported an offering of common stock.
- Worthington Industries, Inc. (NYSE:WOR) declined 9.7 percent to $45.70 after the company reported weaker-than-expected earnings for its third quarter.
- Secureworks Corp (NASDAQ:SCWX) shares dropped 6.7 percent to $9.64. Goldman Sachs downgraded SecureWorks from Buy to Neutral, while Barclays downgraded the stock from Overweight to Equal-Weight.
- OFS Capital Corp (NASDAQ:OFS) fell 5.8 percent to $14.11. OFS Capital commenced an offering of 3.5 million shares of common stock.
- Synergy Pharmaceuticals Inc (NASDAQ:SGYP) declined 3.4 percent to $4.60 following a law firm PR mentioning investigation in potential breaches of fiduciary duty by board of directors.
- Fifth Street Finance Corp. (NASDAQ:FSC) dropped 3.3 percent to $4.54. Raymond James downgraded Fifth Street Finance from Market Perform to Underperform.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!